News
The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback